Global Lacrimal Duct Stent System Market Size By Type (Mono Canalicular Stents, Canalicular Stents), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Lacrimal Duct Stent System Market was valued at USD 238 million in 2023 and is projected to reach USD 412 million by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. The market growth is primarily fueled by the rising prevalence of ophthalmic disorders, especially nasolacrimal duct obstruction (NLDO), increasing geriatric population, and growing awareness of early diagnosis and treatment. Lacrimal duct stent systems are minimally invasive devices used to restore tear drainage and prevent recurrent infections, making them essential in ophthalmic and ENT procedures.

Drivers:

1. Rising Prevalence of Nasolacrimal Duct Obstruction:

NLDO is increasingly common, especially among the elderly and pediatric populations. As the global population ages, the demand for effective treatment options like lacrimal duct stents continues to rise.

2. Technological Advancements in Minimally Invasive Ophthalmic Devices:

Continuous innovations in biocompatible materials, self-retaining stents, and non-surgical insertion techniques are enhancing patient outcomes and reducing recovery times.

3. Increase in Ophthalmic Surgical Volumes Globally:

Improved access to eye care services and increasing number of oculoplastic surgeries are significantly contributing to the growth of this market.

Restraints:

1. Risk of Postoperative Complications:

While generally safe, complications such as infection, stent displacement, or granulation tissue formation may occur, limiting broader adoption in some clinical settings.

2. Limited Availability in Low-Income Regions:

High costs associated with these devices and lack of trained personnel can restrict usage in underdeveloped and rural healthcare settings.

Opportunity:

1. Expansion of Ambulatory Surgical Centers (ASCs):

The proliferation of ASCs offering ophthalmic procedures, especially in urban and semi-urban areas, is expected to boost the demand for lacrimal duct stents.

2. Increasing Focus on Pediatric Ophthalmology:

Congenital NLDO is prevalent among infants, and with rising pediatric care awareness, demand for lacrimal stenting procedures in children is set to grow steadily.

Market by System Type Insights:

In 2023, the monocanalicular stent segment held the largest market share due to its ease of use, patient comfort, and minimal invasiveness. However, the bicanalicular stent segment is expected to witness faster growth over the forecast period, driven by its effectiveness in treating bilateral obstructions and its broader applicability across age groups.

Market by End-use Insights:

Hospitals accounted for the highest revenue share in 2023, owing to their advanced surgical infrastructure and availability of specialized ophthalmic surgeons. Ambulatory Surgical Centers (ASCs) are anticipated to experience the highest growth rate due to shorter procedure times, reduced costs, and patient preference for outpatient care settings.

Market by Regional Insights:

North America dominated the lacrimal duct stent system market in 2023, thanks to high healthcare spending, strong ophthalmic device adoption, and established reimbursement frameworks. However, Asia-Pacific is projected to witness the highest CAGR during the forecast period, driven by the expanding medical tourism sector, increasing eye care awareness, and rising elderly population in countries like China and India.

Competitive Scenario:

Prominent players in the market include FCI Ophthalmics, BVI Medical, Cook Medical, Kaneka Corporation, and Bausch + Lomb. These companies are emphasizing strategic collaborations, R&D investments, and geographic expansion to strengthen their market presence.

Recent Developments:

In 2023, FCI Ophthalmics launched a next-gen self-retaining bicanalicular stent optimized for pediatric use.

Cook Medical received regulatory approval in 2024 for a novel monocanalicular stent designed to reduce post-op infections.

In 2025, BVI Medical partnered with key ophthalmology clinics across Europe to enhance stent availability and training programs.

Scope of Work – Global Lacrimal Duct Stent System Market

Report Metric Details

Market Size (2023) USD 238 million

Projected Market Size (2031) USD 412 million

CAGR (2023–2031) 7.2%

Market Segments By System Type (Monocanalicular, Bicanalicular), By End-use (Hospitals, ASCs), By Region

Growth Drivers Risi